Washington D.C. – U.S. Senator Mike Enzi, R-WY, Ranking Member of the Senate Health, Education, Labor and Pensions Committee (HELP Committee), today voiced his strong support for an amendment to the drug safety bill that would require the Food and Drug Administration (FDA) to review the drug RU-486 by a specific date, but in the same manner...